Measurement of Renal Function With Iohexol in Subjects NCT01392313

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Withdrawn

The investigators will measure renal function in subjects ingesting carnitine to determine if the product alters renal function.

Recruitment information / eligibility
Status	Withdrawn
Enrollment	0
Est. completion date	June 2010
Est. primary completion date	June 2010
Accepts healthy volunteers	Accepts Healthy Volunteers
Gender	All
Age group	18 Years and older
Eligibility	Inclusion Criteria: - carnitine ingestion Exclusion Criteria: - renal disease

Dietary Supplement:
• Carnitine
Carnitine Ingestion
• Placebo
Carnitine placebo

Locations
Country	Name	City	State
United States	Montefiore Medical Center	Bronx	New York

Sponsors *(1)*
Lead Sponsor	Collaborator
Montefiore Medical Center

United States,

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	Iohexol clearance	Iohexol clearance will be measured	1 month